Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

Aug-22

AUTHORS : Li Wei, Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom. Email: l.wei@ucl.ac.uk

JOURNAL : Frontiers in Medicine

REFERENCE: 9:893080

DOI : 10.3389/fmed.2022.893080

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

More publications

Characteristics and Outcomes of Over a Million Patients with Infammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource

Defining Mental Health Conditions Within Primary Care Data: A Validation Study With a Mixed Qualitative and Quantitative Approach

Trends in clinical workload in UK primary care 2005–2019: a retrospective cohort study